Vivo Bio Tech

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE380K01017
NSEID:
BSEID: 511509
View on BSE

INR

21.73

-0.35 (-1.59%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 13.8 k

{
  "main_header": {
    "sid": 650679,
    "name": "Vivo Bio Tech",
    "stock_name": "Vivo Bio Tech",
    "full_name": "Vivo Bio Tech Ltd.",
    "name_url": "stocks-analysis/vivo-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.73",
    "chg": -0.35,
    "chgp": "-1.59%",
    "dir": -1,
    "prev_price": "22.08",
    "mcapval": "49.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 511509,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE380K01017",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "19:00 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "13.8 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivo-bio-tech-650679-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Vivo Bio Tech Ltd. to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-tech-ltd-stock-falls-to-52-week-low-of-rs1836-amidst-continued-downtrend-4126027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivoBioTechLtd_priceRelatedfactors_4126027.png",
        "date": "2026-07-29 12:10:32",
        "description": "For the ninth consecutive session, Vivo Bio Tech Ltd. has closed lower, culminating in a fresh 52-week low of Rs 18.36 on 29 Jul 2026. This persistent decline has dragged the stock down by 12.89% over this period, sharply underperforming its sector and broader indices."
      },
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-4125608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivoBioTechLtd_mojoScore_4125608.png",
        "date": "2026-07-29 10:11:32",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 July 2026, providing investors with the latest insights into the stock’s performance and outlook."
      },
      {
        "title": "Vivo Bio Tech’s Volatile Week: Flat Close Masks Sharp Intraday Swings and Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-techs-volatile-week-flat-close-masks-sharp-intraday-swings-and-margin-pressures-4107509",
        "imagepath": "",
        "date": "2026-07-18 16:04:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Stock surged 6.87% to Rs.25.19 on strong volume</p>\n                    <p><strong>14 Jul:</strong> Quarterly results revealed flat performance with margin pressures; stock fell 7.07% to Rs.23.41</p>\n                    <p><strong>15 Jul:</strong> Minor decline of 0.17% to Rs.23.37 on low volume</p>\n                    <p><strong>16 Jul:</strong> Slight recovery of 0.94% to Rs.23.59</p>\n                    <p><strong>17 Jul:</strong> Week closed flat at Rs.23.57 with negligible change</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n      ..."
      },
      {
        "title": "Are Vivo Bio Tech Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vivo-bio-tech-ltd-latest-results-good-or-bad-4102114",
        "imagepath": "",
        "date": "2026-07-14 19:12:18",
        "description": "Vivo Bio Tech Ltd.'s latest financial results for Q1 FY27 present a complex picture of operational performance contrasted with significant profitability challenges. The company achieved net sales of ₹14.28 crores, reflecting a year-on-year revenue growth of 14.15%, which is the highest quarterly revenue in its recent history. This indicates sustained demand for its contract research services in drug development and discovery segments. However, the net profit sharply declined to ₹0.19 crores, representing an 85.82% year-on-year decrease, raising concerns about the company's ability to convert revenue growth into profit.\n\nThe operating margin for the quarter stood at 35.36%, down from 43.80% in the same quarter last year, indicating a contraction in operational efficiency despite the revenue increase. The profit after tax (PAT) margin also compressed significantly to 1.33%, down from 10.71% year-on-year, high..."
      },
      {
        "title": "Vivo Bio Tech Ltd. Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivo-bio-tech-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4100894",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivoBioTechLtd_fintrenddot_4100894.png",
        "date": "2026-07-14 11:00:08",
        "description": "Vivo Bio Tech Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a pause in its recent downward trend. Despite achieving its highest quarterly net sales and improved operational metrics, the company continues to grapple with margin pressures and a subdued return on capital employed, reflecting ongoing challenges in its business environment."
      },
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-4100612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivoBioTechLtd_mojoScore_4100612.png",
        "date": "2026-07-14 10:11:27",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 July 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Vivo Bio Tech Q1 FY27: Profit Plunges 85.82% Despite Revenue Growth as Tax Anomaly Haunts",
        "link": "https://www.marketsmojo.com/news/result-analysis/vivo-bio-tech-q1-fy27-profit-plunges-8582-despite-revenue-growth-as-tax-anomaly-haunts-4100932",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VivoBioTech_quaterlyResult_4100932.png",
        "date": "2026-07-14 09:46:55",
        "description": "Vivo Bio Tech Limited, a contract research organisation specialising in drug development services, reported a concerning Q1 FY27 performance with net profit collapsing 85.82% year-on-year to ₹0.19 crores despite modest revenue growth. The micro-cap pharmaceutical services company, with a market capitalisation of ₹54.00 crores, saw its stock decline 4.72% to ₹24.00 following the results announcement, extending its bearish trend that has persisted since June 2026."
      },
      {
        "title": "When is the next results date for Vivo Bio Tech Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vivo-bio-tech-ltd-4094112",
        "imagepath": "",
        "date": "2026-07-08 23:16:04",
        "description": "The next results date for Vivo Bio Tech Ltd. is scheduled for 13 July 2026...."
      },
      {
        "title": "Vivo Bio Tech Ltd. is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivo-bio-tech-ltd-is-rated-strong-sell-4078737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivoBioTechLtd_mojoScore_4078737.png",
        "date": "2026-06-30 10:10:55",
        "description": "Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 30 June 2026, providing investors with the latest view of the company’s position in the market."
      }
    ],
    "total": 120,
    "sid": "650679",
    "stock_news_url": "https://www.marketsmojo.com/news/vivo-bio-tech-650679"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Jul-2026",
      "details": "Please find enclosed Newspaper publication for financial results.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "14-Jul-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "14-Jul-2026",
      "details": "Please find enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Vivo Bio Tech Ltd. to a New 52-Week Low

2026-07-29 12:10:32

For the ninth consecutive session, Vivo Bio Tech Ltd. has closed lower, culminating in a fresh 52-week low of Rs 18.36 on 29 Jul 2026. This persistent decline has dragged the stock down by 12.89% over this period, sharply underperforming its sector and broader indices.

Read full news article

Vivo Bio Tech Ltd. is Rated Strong Sell

2026-07-29 10:11:32

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 July 2026, providing investors with the latest insights into the stock’s performance and outlook.

Read full news article

Vivo Bio Tech’s Volatile Week: Flat Close Masks Sharp Intraday Swings and Margin Pressures

2026-07-18 16:04:22

Key Events This Week

13 Jul: Stock surged 6.87% to Rs.25.19 on strong volume

14 Jul: Quarterly results revealed flat performance with margin pressures; stock fell 7.07% to Rs.23.41

15 Jul: Minor decline of 0.17% to Rs.23.37 on low volume

16 Jul: Slight recovery of 0.94% to Rs.23.59

17 Jul: Week closed flat at Rs.23.57 with negligible change

Week Open

...

Read full news article

Are Vivo Bio Tech Ltd. latest results good or bad?

2026-07-14 19:12:18

Vivo Bio Tech Ltd.'s latest financial results for Q1 FY27 present a complex picture of operational performance contrasted with significant profitability challenges. The company achieved net sales of ₹14.28 crores, reflecting a year-on-year revenue growth of 14.15%, which is the highest quarterly revenue in its recent history. This indicates sustained demand for its contract research services in drug development and discovery segments. However, the net profit sharply declined to ₹0.19 crores, representing an 85.82% year-on-year decrease, raising concerns about the company's ability to convert revenue growth into profit. The operating margin for the quarter stood at 35.36%, down from 43.80% in the same quarter last year, indicating a contraction in operational efficiency despite the revenue increase. The profit after tax (PAT) margin also compressed significantly to 1.33%, down from 10.71% year-on-year, high...

Read full news article

Vivo Bio Tech Ltd. Reports Flat Quarterly Performance Amid Margin Pressures

2026-07-14 11:00:08

Vivo Bio Tech Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a pause in its recent downward trend. Despite achieving its highest quarterly net sales and improved operational metrics, the company continues to grapple with margin pressures and a subdued return on capital employed, reflecting ongoing challenges in its business environment.

Read full news article

Vivo Bio Tech Ltd. is Rated Strong Sell

2026-07-14 10:11:27

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 July 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

Vivo Bio Tech Q1 FY27: Profit Plunges 85.82% Despite Revenue Growth as Tax Anomaly Haunts

2026-07-14 09:46:55

Vivo Bio Tech Limited, a contract research organisation specialising in drug development services, reported a concerning Q1 FY27 performance with net profit collapsing 85.82% year-on-year to ₹0.19 crores despite modest revenue growth. The micro-cap pharmaceutical services company, with a market capitalisation of ₹54.00 crores, saw its stock decline 4.72% to ₹24.00 following the results announcement, extending its bearish trend that has persisted since June 2026.

Read full news article

When is the next results date for Vivo Bio Tech Ltd.?

2026-07-08 23:16:04

The next results date for Vivo Bio Tech Ltd. is scheduled for 13 July 2026....

Read full news article

Vivo Bio Tech Ltd. is Rated Strong Sell

2026-06-30 10:10:55

Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 30 June 2026, providing investors with the latest view of the company’s position in the market.